AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Paratek PharmaceuticalsFortress BiotechNewron PharmaceuticalsCerecorvTv Therapeutics
SymbolNASDAQ:PRTKNASDAQ:FBIOOTCMKTS:NWPHFNASDAQ:CERCNASDAQ:VTVT
Price Information
Current Price$4.58$3.16$8.90$2.96$2.89
52 Week RangeBuyBuyN/ABuyBuy
Beat the Market™ Rank
Overall Score1.51.30.62.41.8
Analysis Score3.53.50.03.43.5
Community Score2.62.62.22.92.6
Dividend Score0.00.00.00.00.0
Ownership Score1.00.00.05.03.0
Earnings & Valuation Score0.60.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$18.50$9.20N/A$10.50$7.00
% Upside from Price Target303.93% upside191.14% upsideN/A254.73% upside142.21% upside
Trade Information
Market Cap$197.54 million$247.41 million$158.87 million$192.53 million$191.79 million
Beta1.542.150.161.88-1.84
Average Volume790,697548,7991,600168,906628,992
Sales & Book Value
Annual Revenue$16.54 million$36.63 million$7.88 million$6.75 million$2.76 million
Price / Sales11.947.1120.1626.1470.97
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($1.19) per share$1.02 per share$2.31 per share$0.40 per share($0.77) per share
Price / Book-3.853.103.857.40-3.75
Profitability
Net Income$-128,790,000.00$-39,960,000.00$-22,630,000.00$-16,070,000.00$-13,040,000.00
EPS($3.93)($0.73)($1.27)($0.30)($0.37)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/A11.41N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-528.28%-124.73%N/AN/A-870.88%
Return on Equity (ROE)-5,327.73%-58.31%N/A-68.23%N/A
Return on Assets (ROA)-47.65%-20.17%N/A-28.57%-150.44%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A1.26%0.46%N/AN/A
Current Ratio5.27%3.07%10.72%1.66%0.29%
Quick Ratio4.95%3.05%10.71%1.66%0.29%
Ownership Information
Institutional Ownership Percentage43.41%15.79%N/A59.90%8.23%
Insider Ownership Percentage8.30%33.10%N/A58.00%1.50%
Miscellaneous
Employees10193246452
Shares Outstanding43.13 million82.47 million17.85 million59.61 million67.77 million
Next Earnings Date8/4/2020 (Estimated)8/14/2020 (Estimated)6/4/2020 (Estimated)8/13/2020 (Estimated)7/29/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.